Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic AcidNCT00007020MIRMPhase 3Completed2009-12Actual
Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated AdultsNCT00053482Emergent BioSolutionsPhase 2Completed2003-04Actual
Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox VaccinationNCT00053495Emergent BioSolutionsPhase 2Completed2003-06Actual
A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent LymphomaNCT00081809AGENPhase 2Completed2005-06Actual
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)NCT00091637Procter and GamblePhase 3Completed2007-05Actual
Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access GraftsNCT00131872LeMaitre VascularPhase 2Terminated—
Study of Oxycyte in Severe Closed Head InjuryNCT00174980TENXPhase 2Terminated2008-03Actual
Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)NCT00231062Integra LifeSciences CorporationPhase 3Completed2006-06Actual
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaNCT00254202Vanda PharmaceuticalsPhase 3Completed2006-09-26Actual
Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis PatientsNCT00280917Can-Fite BioPharmaPhase 2Completed2007-04Actual
Safety and Efficacy of Prochymal for the Salvage of Treatment-Refractory Acute GVHD ParticipantsNCT00284986Mesoblast, Inc.Phase 2Completed2006-04-25Actual
The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes MellitusNCT00385697MacroGenicsPhase 2, Phase 3Completed2010-06Actual
Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's DiseaseNCT00482092Mesoblast, Inc.Phase 3Completed2014-09-15Actual
ACP-104 in Acutely Psychotic Subjects With SchizophreniaNCT00490516ACADPhase 2Completed2008-02Actual
Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's DiseaseNCT00543374Mesoblast, Inc.Phase 3Completed2009-07Actual
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant GliomaNCT00589875CADLPhase 2Completed2015-12Actual
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)NCT00617981ImunonPhase 3Completed2013-01Actual
Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic CancerNCT00625586MacroGenicsPhase 2Terminated2009-01-21Actual
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct ProblemsNCT00626236SUPNPhase 2Completed2009-09-23Actual
Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy AdultsNCT00679172Emergent BioSolutionsPhase 2Completed2008-12Actual
PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT00683722Mesoblast, Inc.Phase 2Completed2009-03-09Actual
PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)NCT00690066Mesoblast, Inc.Phase 2Completed2010-12-12Actual
Study of XL184 (Cabozantinib) in Adults With Glioblastoma MultiformeNCT00704288ExelixisPhase 2Completed2012-06Actual
A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on ErlotinibNCT00750698Syndax PharmaceuticalsPhase 2Terminated2010-05Actual
HuMax-CD4 in Non-Cutaneous T-Cell LymphomaNCT00877656Emergent BioSolutionsPhase 2, Phase 3Completed2006-01Actual
Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)NCT00877903Mesoblast, Inc.Phase 2Completed2011-05-18Actual
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell LymphomaNCT00893516Emergent BioSolutionsPhase 2Terminated2008-10Actual
Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246NCT00907803SIGA TechnologiesPhase 2Completed2010-01Actual
Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes MellitusNCT00920582MacroGenicsPhase 3Terminated2012-04Actual
Study of Cabozantinib (XL184) in Adults With Advanced MalignanciesNCT00940225ExelixisPhase 2Completed2013-05Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.